Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15151-15200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03777215
Angiotensin-(1-7) and Energy Expenditure in Human Obesity
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Sep 26, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04033445
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE2/PHASE3
Active, not recruiting
1,064 participants
Started: Sep 26, 2019 · Completed: Oct 27, 2027
1 condition
1 sponsor
391 locations
NCT06727357
"Next Generation Sequencing-based Oncochip for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP"
PHASE2
Active, not recruiting
38 participants
Started: Sep 26, 2019 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT03900884
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
PHASE1
Active, not recruiting
17 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT03933904
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
PHASE2
Active, not recruiting
7 participants
Started: Sep 25, 2019 · Completed: Jun 30, 2026
2 conditions
1 sponsor
4 locations
NCT04069299
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
N/A
Active, not recruiting
30 participants
Started: Sep 25, 2019 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT04018859
Platelet-rich Plasma for Eyebrows
PHASE2
Active, not recruiting
11 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04136054
Better Sleep in Psychiatric Care - Depression, Anxiety and PTSD
NA
Active, not recruiting
130 participants
Started: Sep 25, 2019 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT03803774
Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma
PHASE1
Active, not recruiting
13 participants
Started: Sep 25, 2019 · Completed: Jul 9, 2026
3 conditions
1 sponsor
33 locations
NCT04060927
Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the Lung
NA
Active, not recruiting
45 participants
Started: Sep 25, 2019 · Completed: Oct 31, 2026
1 condition
2 sponsors
1 location
NCT03915184
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
PHASE1/PHASE2
Active, not recruiting
105 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2034
1 condition
1 sponsor
13 locations
NCT03999424
Autologous Human Schwann Cells in Peripheral Nerve Repair
PHASE1
Active, not recruiting
5 participants
Started: Sep 24, 2019 · Completed: Sep 1, 2026
1 condition
2 sponsors
1 location
NCT04090736
Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy
PHASE3
Active, not recruiting
302 participants
Started: Sep 24, 2019 · Completed: Jun 30, 2025
1 condition
3 sponsors
62 locations
NCT04106414
Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
PHASE2
Active, not recruiting
24 participants
Started: Sep 24, 2019 · Completed: Sep 30, 2026
2 conditions
2 sponsors
7 locations
NCT05726617
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders
NA
Active, not recruiting
32 participants
Started: Sep 24, 2019 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT04611503
PDE6A Gene Therapy for Retinitis Pigmentosa
PHASE1/PHASE2
Active, not recruiting
9 participants
Started: Sep 24, 2019 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT04093596
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
PHASE1
Active, not recruiting
132 participants
Started: Sep 23, 2019 · Completed: Sep 30, 2027
1 condition
1 sponsor
11 locations
NCT03917082
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
PHASE2
Active, not recruiting
290 participants
Started: Sep 23, 2019 · Completed: May 1, 2029
2 conditions
3 sponsors
1 location
NCT03657576
Trial of C134 in Patients With Recurrent GBM
PHASE1
Active, not recruiting
19 participants
Started: Sep 23, 2019 · Completed: Sep 30, 2026
3 conditions
3 sponsors
1 location
NCT03130244
Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes
NA
Active, not recruiting
15 participants
Started: Sep 23, 2019 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT04040088
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors
EARLY_PHASE1
Active, not recruiting
20 participants
Started: Sep 23, 2019 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT04704609
Imaging Quantification of Inflammation (IQI)
N/A
Active, not recruiting
50 participants
Started: Sep 22, 2019 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT03781063
Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
PHASE2
Active, not recruiting
100 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2024
1 condition
2 sponsors
51 locations
NCT04095364
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
Active, not recruiting
450 participants
Started: Sep 20, 2019 · Completed: Feb 1, 2028
12 conditions
2 sponsors
911 locations
NCT03950076
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
PHASE4
Active, not recruiting
948 participants
Started: Sep 20, 2019 · Completed: Oct 31, 2026
2 conditions
1 sponsor
152 locations
NCT04067713
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
N/A
Active, not recruiting
192 participants
Started: Sep 20, 2019 · Completed: Oct 1, 2030
1 condition
2 sponsors
16 locations
NCT04083339
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
PHASE3
Active, not recruiting
675 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
79 locations
NCT03993925
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
N/A
Active, not recruiting
800 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03940703
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
PHASE2
Active, not recruiting
140 participants
Started: Sep 19, 2019 · Completed: Oct 31, 2025
1 condition
2 sponsors
179 locations
NCT04023370
Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System
NA
Active, not recruiting
182 participants
Started: Sep 19, 2019 · Completed: Aug 31, 2025
1 condition
2 sponsors
12 locations
NCT04029714
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
NA
Active, not recruiting
195 participants
Started: Sep 19, 2019 · Completed: Dec 31, 2033
1 condition
3 sponsors
5 locations
NCT04961710
Extension Study of Hetrombopag in Severe Aplastic Anemia
PHASE3
Active, not recruiting
157 participants
Started: Sep 19, 2019 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04169191
Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia
PHASE1
Active, not recruiting
20 participants
Started: Sep 19, 2019 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04146818
Study of the Effects of Adapted Tango and Multidimensional Intervention in pREvention of Dementia in agiNG (STRENGTH)
NA
Active, not recruiting
300 participants
Started: Sep 19, 2019 · Completed: Jun 29, 2024
1 condition
2 sponsors
1 location
NCT05586750
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
PHASE4
Active, not recruiting
341 participants
Started: Sep 19, 2019 · Completed: Sep 30, 2026
7 conditions
2 sponsors
2 locations
NCT04024163
Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
PHASE3
Active, not recruiting
178 participants
Started: Sep 19, 2019 · Completed: Mar 30, 2028
1 condition
2 sponsors
9 locations
NCT02595879
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
PHASE1
Active, not recruiting
21 participants
Started: Sep 18, 2019 · Completed: Apr 29, 2026
13 conditions
1 sponsor
17 locations
NCT03305250
Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease
NA
Active, not recruiting
169 participants
Started: Sep 18, 2019 · Completed: Jul 31, 2027
1 condition
7 sponsors
7 locations
NCT04094961
Ixazomib + Pomalidomide + Dexamethasone In MM
PHASE1/PHASE2
Active, not recruiting
52 participants
Started: Sep 18, 2019 · Completed: Jan 1, 2027
2 conditions
2 sponsors
1 location
NCT03952351
Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography
NA
Active, not recruiting
3,170 participants
Started: Sep 18, 2019 · Completed: Feb 28, 2026
1 condition
5 sponsors
9 locations
NCT04098393
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
PHASE1
Active, not recruiting
39 participants
Started: Sep 18, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT07024914
Effect of Oxygen Supplementation on Cerebral Oxygenation, Symptoms and Performance During STST in COPD Patients
NA
Active, not recruiting
25 participants
Started: Sep 18, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04186013
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer
PHASE2
Active, not recruiting
39 participants
Started: Sep 18, 2019 · Completed: May 31, 2027
1 condition
3 sponsors
10 locations
NCT04281771
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
NA
Active, not recruiting
92 participants
Started: Sep 17, 2019 · Completed: Oct 28, 2026
6 conditions
1 sponsor
1 location
NCT04083599
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
PHASE1/PHASE2
Active, not recruiting
350 participants
Started: Sep 17, 2019 · Completed: Nov 30, 2026
6 conditions
2 sponsors
76 locations
NCT04011722
Portico Next Generation Approval Study
NA
Active, not recruiting
333 participants
Started: Sep 17, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
28 locations
NCT04008706
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
PHASE3
Active, not recruiting
552 participants
Started: Sep 17, 2019 · Completed: Oct 31, 2025
1 condition
2 sponsors
108 locations
NCT04002141
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
PHASE2
Active, not recruiting
65 participants
Started: Sep 17, 2019 · Completed: Jan 1, 2025
2 conditions
1 sponsor
1 location
NCT04095234
Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)
PHASE2
Active, not recruiting
300 participants
Started: Sep 17, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
8 locations
NCT04108897
Analysis of the Microbiome in Rosacea
EARLY_PHASE1
Active, not recruiting
150 participants
Started: Sep 17, 2019 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
301
302
303
304
305
306
307
More pages
431
Next